CO4910166A1 - Compuestos 2-imidazolinilaminoindazol utiles como agonistas de 2-alfa adrenoceptores - Google Patents
Compuestos 2-imidazolinilaminoindazol utiles como agonistas de 2-alfa adrenoceptoresInfo
- Publication number
- CO4910166A1 CO4910166A1 CO97068615A CO97068615A CO4910166A1 CO 4910166 A1 CO4910166 A1 CO 4910166A1 CO 97068615 A CO97068615 A CO 97068615A CO 97068615 A CO97068615 A CO 97068615A CO 4910166 A1 CO4910166 A1 CO 4910166A1
- Authority
- CO
- Colombia
- Prior art keywords
- hydrogen
- compounds
- imidazolinylaminindazole
- compounds useful
- alkanyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Resins (AREA)
Abstract
La presente invención se relaciona con compuestos que tienenla siguiente estructura en donde: a) R1 es hidrógeno; o alquilo; b) R2 es hidrógeno; o alquilo o nada; c) R3 se selecciona de hidrógeno; alcanilo C1 -C3 insustituido; amino; hidroxi; mercapto; alquiltio o alcoxi; alquilamino C1 -C3 ; o dialquilamino C1 -C3 ; ciano y halo; d) R4 , R5 y R7 se seleccionan cada uno independientemente de hidrógeno; alcanilo, alquenilo o alquinilo C1 -C3 insustituido; amino; hidroxi; mercapto; alquiltio o alcoxi C1 -C3 ; tio; nitro; ciano; amino; alquilamino C1 -C3 ; dialquilamino C1 -C3 ;e) cuando R2 es nada, el enlace (a) es un enlace doble; f) el compuesto no es 7-bromo-6-(2- imidazolinilamino)-indazol; y enantiómeros, isómeros ópticos, estereoisómeros, diastereómeros, tautómeros, sales de adición, amidas y ésteres biohidrolizables, y composiciones farmacéuticas que contienen tales nuevos compuestos, y el uso de tales compuestos para prevenir o tratar trastornos modulados por alfa-2 adrenoceptores.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3174096P | 1996-11-25 | 1996-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4910166A1 true CO4910166A1 (es) | 2000-04-24 |
Family
ID=21861136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97068615A CO4910166A1 (es) | 1996-11-25 | 1997-11-24 | Compuestos 2-imidazolinilaminoindazol utiles como agonistas de 2-alfa adrenoceptores |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0944620A1 (es) |
| JP (1) | JP2001506599A (es) |
| KR (1) | KR20000069104A (es) |
| CN (1) | CN1244864A (es) |
| AR (1) | AR010643A1 (es) |
| AU (1) | AU5433998A (es) |
| BR (1) | BR9713535A (es) |
| CA (1) | CA2272644A1 (es) |
| CO (1) | CO4910166A1 (es) |
| CZ (1) | CZ183999A3 (es) |
| HU (1) | HUP9904660A3 (es) |
| ID (1) | ID22676A (es) |
| IL (1) | IL130067A0 (es) |
| NO (1) | NO992502L (es) |
| NZ (1) | NZ335882A (es) |
| PE (1) | PE47099A1 (es) |
| SK (1) | SK69699A3 (es) |
| TR (1) | TR199901542T2 (es) |
| WO (1) | WO1998023609A1 (es) |
| ZA (1) | ZA9710576B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
| EP2226315A4 (en) | 2007-12-28 | 2012-01-25 | Carna Biosciences Inc | 2-AMINOQUINAZOLINE DERIVATIVE |
| WO2010074753A1 (en) | 2008-12-23 | 2010-07-01 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
| CN112538074A (zh) * | 2020-12-24 | 2021-03-23 | 艾希尔（深圳）药物研发有限公司 | 一种溴莫尼定脱溴杂质的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH641782A5 (en) * | 1978-12-07 | 1984-03-15 | Siegfried Ag | 1H- and 2H-indazole derivatives |
| US4526898A (en) * | 1980-09-05 | 1985-07-02 | Siegfried Aktiengesselschaft | Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole |
| CN1137755A (zh) * | 1993-12-17 | 1996-12-11 | 普罗克特和甘保尔公司 | 用作α-2肾上腺素能受体兴奋剂的6-(2-咪唑啉基氨基)喹喔啉化合物 |
| US5478858A (en) * | 1993-12-17 | 1995-12-26 | The Procter & Gamble Company | 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists |
-
1997
- 1997-11-21 CA CA002272644A patent/CA2272644A1/en not_active Abandoned
- 1997-11-21 IL IL13006797A patent/IL130067A0/xx unknown
- 1997-11-21 KR KR1019997004569A patent/KR20000069104A/ko not_active Application Discontinuation
- 1997-11-21 HU HU9904660A patent/HUP9904660A3/hu unknown
- 1997-11-21 EP EP97948238A patent/EP0944620A1/en not_active Withdrawn
- 1997-11-21 TR TR1999/01542T patent/TR199901542T2/xx unknown
- 1997-11-21 WO PCT/US1997/020551 patent/WO1998023609A1/en not_active Application Discontinuation
- 1997-11-21 AU AU54339/98A patent/AU5433998A/en not_active Abandoned
- 1997-11-21 JP JP52468698A patent/JP2001506599A/ja active Pending
- 1997-11-21 ID IDW990412A patent/ID22676A/id unknown
- 1997-11-21 CN CN97181453A patent/CN1244864A/zh active Pending
- 1997-11-21 CZ CZ991839A patent/CZ183999A3/cs unknown
- 1997-11-21 BR BR9713535A patent/BR9713535A/pt unknown
- 1997-11-21 NZ NZ335882A patent/NZ335882A/xx unknown
- 1997-11-24 CO CO97068615A patent/CO4910166A1/es unknown
- 1997-11-25 ZA ZA9710576A patent/ZA9710576B/xx unknown
- 1997-11-25 AR ARP970105524A patent/AR010643A1/es unknown
- 1997-11-25 PE PE1997001067A patent/PE47099A1/es not_active Application Discontinuation
-
1999
- 1999-05-25 NO NO992502A patent/NO992502L/no not_active Application Discontinuation
- 1999-05-25 SK SK696-99A patent/SK69699A3/sk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO992502D0 (no) | 1999-05-25 |
| JP2001506599A (ja) | 2001-05-22 |
| ZA9710576B (en) | 1998-09-16 |
| CZ183999A3 (cs) | 1999-11-17 |
| BR9713535A (pt) | 2000-03-21 |
| PE47099A1 (es) | 1999-06-12 |
| SK69699A3 (en) | 2000-06-12 |
| CA2272644A1 (en) | 1998-06-04 |
| AU5433998A (en) | 1998-06-22 |
| CN1244864A (zh) | 2000-02-16 |
| TR199901542T2 (xx) | 2000-01-21 |
| KR20000069104A (ko) | 2000-11-25 |
| HUP9904660A2 (hu) | 2000-06-28 |
| NO992502L (no) | 1999-07-26 |
| NZ335882A (en) | 2000-12-22 |
| IL130067A0 (en) | 2000-02-29 |
| EP0944620A1 (en) | 1999-09-29 |
| WO1998023609A1 (en) | 1998-06-04 |
| HUP9904660A3 (en) | 2002-02-28 |
| ID22676A (id) | 1999-12-09 |
| AR010643A1 (es) | 2000-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4910149A1 (es) | Compuestos de 2-imidazolinilaminoindol utiles como agonistas de alfa-2 adrenoceptores | |
| CO4910148A1 (es) | Compuestos heterociclicos de guanidinilo utiles como agonis- tas de alfa-2 adrenoceptores | |
| AR002955A1 (es) | Un compuesto heterocíclico substituido, procedimiento y compuestos intermediarios para su preparación y composición farmacéutica que contiene a dicho compuesto. | |
| AR040773A1 (es) | Pirazoles utiles como inhibidores de gsk-3 | |
| CO5700824A2 (es) | Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| AR059895A1 (es) | Derivados biciclicos de acidos carboxilicos que resultan de utilidad para tratar trastornos metabolicos | |
| AR067663A1 (es) | Derivados heterociclicos de etiloxi amidas, composiciones que los comprenden y usos de los mismos en agricultura u horticultura, como agentes antifungicos. | |
| HRP20031098B1 (en) | Beta-amino tetrahydroimidazo (1,2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | |
| MX9300031A (es) | Derivados de piperazina, procedimiento para su preparacion y composicion farmaucetica que los contiene. | |
| CO5160347A1 (es) | Derivados de acido carbamico | |
| AR018186A1 (es) | Compuestos de carbazoly de 1,2,3,4-tetrahidrocarbazol sustituidos, utiles como inhibidores de la liberacion de acidos grasos mediada por spla2,procedimiento para prepararlos; compuestos intermediarios de aplicacion en dichos procedimientos; composiciones farmaceuticas que comprenden dichos compuesto | |
| AR026352A1 (es) | Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii. | |
| CO4910150A1 (es) | Compuestos de 2-imidazolinilaminobenzoxazol utiles con agonistas de alfa-2 adrenoceptores | |
| AR022019A1 (es) | Un compuesto de imidazol y las composiciones farmaceuticas que lo contienen | |
| AR002690A1 (es) | Derivado de bencimidazol o sales del mismo, composicion farmaceutica, agente inmunosupresor y agente antiinflamatorio que lo contienen yprocedimientos para preparar dicho derivado. | |
| NZ513594A (en) | Heterocyclic compounds, intermediates thereof and elastase inhibitors | |
| UY24429A1 (es) | Acetidinas | |
| PE78898A1 (es) | Derivados de 2,4-diaminopirimidinas | |
| CO4910166A1 (es) | Compuestos 2-imidazolinilaminoindazol utiles como agonistas de 2-alfa adrenoceptores | |
| ES2249636T3 (es) | Triazoles como antagonistas de la oxitocina. | |
| CO4910168A1 (es) | Compuestos de 2-imidazolinilaminobenzotiazol utiles como agonistas de alfa-2 adrenoceptores | |
| DE69528978D1 (de) | Lactamverbindungen als Inhibitoren der Cholesterin-Esterase | |
| CO4910167A1 (es) | Compuestos heterociclicos de guanidinilamino utiles como agonistas de alfa-2 adrenoceptores | |
| CA2272098A1 (en) | Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists | |
| ES2183500T3 (es) | Nuevos compuestos y composiciones farmaceuticas que los contienen. |